Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels

Carcinogenesis

Volumn 32, Issue 6, 2011, Pages 853-859

  Penney, Kathryn L ^a,b   Schumacher, Fredrick R ^c   Kraft, Peter ^a   Mucci, Lorelei A ^a,b   Sesso, Howard D ^b   Ma, Jing ^b   Niu, Yuxin ^d   Cheong, Jit Kong ^e   Hunter, David J ^a,b   Stampfer, Meir J ^a,b   Hsu, Stephen I ^b,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN RELATED PEPTIDASE 3; PEPTIDASE; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79958227889     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr050     Document Type: Article

References (33)

1. Stamey,T.A. et al. (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med., 317, 909-916.
2. Amundadottir,L.T. et al. (2006) A common variant associated with prostate cancer in European and African populations. Nat. Genet., 38, 652-658.
3. Freedman,M.L. et al. (2006) Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc. Natl Acad. Sci. USA, 103, 14068-14073.
4. Gudmundsson,J. et al. (2007) Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat. Genet., 39, 977-983.
5. Yeager,M. et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet., 39, 645-649.
6. Gudmundsson,J. et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet., 39, 631-637.
7. Gudmundsson,J. et al. (2008) Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat. Genet., 40, 281-283.
8. Eeles,R.A. et al. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet., 40, 316-321.
9. Eeles,R.A. et al. (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat. Genet., 41, 1116-1121.
10. Gudmundsson,J. et al. (2009) Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat. Genet., 41, 1122-1126.
11. Yeager,M. et al. (2009) Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat. Genet., 41, 1055-1057.
12. Ahn,J. et al. (2008) Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat. Genet., 401032-4; author reply, 1035-1036.
13. Xu,J. et al. (2008) Association of prostate cancer risk variants with clinicopathologic characteristics of the disease. Clin. Cancer Res., 14, 5819-5824.
14. Kader,A.K. et al. (2009) Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients. Prostate, 69, 1195-1205.
15. Eeles,R. et al. (2008) Reply to "Variation in KLK genes, prostate-specific antigen and risk of prostate cancer". Nat. Genet., 40, 1035-1036.
16. Hooker,S. et al. (2010) Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans. Prostate, 70, 270-275.
17. Pal,P. et al. (2007) Tagging SNPs in the kallikrein genes 3 and 2 on 19q13 and their associations with prostate cancer in men of European origin. Hum. Genet., 122, 251-259.
18. Lai,J. et al. (2007) PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility. Carcinogenesis, 28, 1032-1039.
19. Severi,G. et al. (2006) Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA. Cancer Epidemiol. Biomarkers Prev., 15, 1142-1147.
20. Fitzgerald,L.M. et al. (2009) Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Clin. Cancer Res., 15, 3231-3237.
21. Gallagher,D.J. et al. (2010) Susceptibility loci associated with prostate cancer progression and mortality. Clin. Cancer Res., 16, 2819-2832.
22. Wiklund,F. et al. (2009) Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. Prostate, 69, 419-427.
23. Cramer,S.D. et al. (2003) Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels. J. Natl Cancer Inst., 95, 1044-1053.
24. Maeda,H. et al. (2009) Prostate-specific antigen enhances bioavailability of insulin-like growth factor by degrading insulin-like growth factor binding protein 5. Biochem. Biophys. Res. Commun., 381, 311-316.
25. Cohen,P. et al. (1994) Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J. Endocrinol., 142, 407-415.
26. Rowlands,M.A. et al. (2009) Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int. J. Cancer, 124, 2416-2429.
27. Chan,J.M. et al. (2002) Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J. Natl Cancer Inst., 94, 1099-1106.
28. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N. Engl. J. Med., 321, 129-135.
29. Venter,J.C. et al. (2001) The sequence of the human genome. Science, 291, 1304-1351.
30. David,A. et al. (2002) Unusual alternative splicing within the human kallikrein genes KLK2 and KLK3 gives rise to novel prostate-specific proteins. J. Biol. Chem., 277, 18084-18090.
31. Michael,I.P. et al. (2005) Intron retention: a common splicing event within the human kallikrein gene family. Clin. Chem., 51, 506-515.
32. Gann,P.H. et al. (2002) Strategies combining total and percent free prostate specific antigen for detecting prostate cancer: a prospective evaluation. J. Urol., 167, 2427-2434.
33. Conneely,K.N. et al. (2007) So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. Am. J. Hum. Genet., 81.